| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000008830 |
| Receipt No. | R000010371 |
| Official scientific title of the study | Effects of levobupivacaine containing low molecular weight dextran on transversus abdominis plane block and rectus sheath block |
| Date of disclosure of the study information | 2012/09/01 |
| Last modified on | 2016/06/01 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Effects of levobupivacaine containing low molecular weight dextran on transversus abdominis plane block and rectus sheath block | |
| Title of the study (Brief title) | Effect of LMWD addition on local anesthetics activity | |
| Region |
|
|
| Condition | |||
| Condition | abdominal diseases receiving laparoscopic surgery | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aim of the present study is investigation of the effect of additiono of low molecular weight dextran to local anesthetics in patients receiving transversus abdominis plane block and rectus sheath block. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | postoperative pain
plasma concentration of levobupivacaine |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | TAP block and RSB with levobupivacaine diluted by saline are performed just before start of operation. | |
| Interventions/Control_2 | TAP block and RSB with levobupivacaine diluted by low molecular weight dextran are performed just before start of operation. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients receiving laparoscopic abdominal surgery | |||
| Key exclusion criteria | patients with emergency surgery
patients under unconscious state |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiko Tsuchiya |
| Organization | Osaka City University Medical School |
| Division name | Department of Anesthesiology |
| Address | 1-5-7 Asah-machi, Abeno-ku, Osaka, Japan |
| TEL | 06-6645-2186 |
| Public contact | |
| Name of contact person | Masahiko Tsuchiya |
| Organization | Osaka CIty University Medical School |
| Division name | Department of Anesthesiology |
| Address | 1-5-7 Asah-machi, Abeno-ku, Osaka, Japan |
| TEL | |
| Homepage URL | |
| Sponsor | |
| Institute | Osaka City University Medical School
Department of Anesthesiology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010371 |